Top compounds associated with response to DAND5


Feature Type Standardized
Nominal ANOVA
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA ISOX CTRPv2 pan-cancer AAC 0.14 5e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.13 5e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.14 6e-06
mRNA alisertib CTRPv2 pan-cancer AAC 0.14 7e-06
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.15 1e-05
Download CSV